Keith Crandell's Net Worth

$2.3 Billion

Estimate Recalculated Mar 1, 2024 04:18PM EST

Who is Keith Crandell?

Keith Crandell has an estimated net worth of $2.3 Billion. This is based on reported shares across multiple companies, which include Sana Biotechnology, Inc., KYTHERA BIOPHARMACEUTICALS INC, ALNYLAM PHARMACEUTICALS INC, PHASERX, INC., APROPOS TECHNOLOGY INC, Neumora Therapeutics, Inc., Lyell Immunopharma, Inc., ADESTO TECHNOLOGIES Corp, IMPINJ INC, AGIOS PHARMACEUTICALS INC, NeurogesX Inc, VBI VACCINES INC., Receptos, Inc., CELEBRATE EXPRESS, INC., DA32 Life Science Tech Acquisition Corp., Gossamer Bio, Inc., Scholar Rock Holding Corp, Erasca, Inc., 908 Devices Inc., Pulmatrix, Inc., Karuna Therapeutics, Inc., Quanterix Corp, Verve Therapeutics, Inc., bluebird bio, Inc., Denali Therapeutics Inc., FATE THERAPEUTICS INC, Twist Bioscience Corp, Sage Therapeutics, Inc., Vir Biotechnology, Inc., Beam Therapeutics Inc., Metacrine, Inc., Bellerophon Therapeutics, Inc., XCYTE THERAPIES INC, Unity Biotechnology, Inc., Syros Pharmaceuticals, Inc., Codiak BioSciences, Inc., Sienna Biopharmaceuticals, Inc., Juno Therapeutics, Inc., Homology Medicines, Inc., ILLUMINA INC, Prime Medicine, Inc., Achaogen Inc, XTERA COMMUNICATIONS, INC., and Trubion Pharmaceuticals, Inc.

SEC CIK

Keith Crandell's CIK is 0001219039

Past Insider Trading and Trends

2021 was Keith Crandell's most active year for acquiring shares with 75 total transactions. Keith Crandell's most active month to acquire stocks was the month of September. 2021 was Keith Crandell's most active year for disposing of shares, totalling 86 transactions. Keith Crandell's most active month to dispose stocks was the month of April. 2023 saw Keith Crandell paying a total of $31,456,134.18 for 19,486,996 shares, this is the most they've acquired in one year. In 2020 Keith Crandell cashed out on 46,808,081 shares for a total of $7,755,000.00, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

IMPINJ INC (PI) Snapshot price: $106.565

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4/A
1.37M
$10.73
$204.50
1.37M
Jul 26
Form 4
1.36M
$11.66
$68.32
1.36M
Jul 26
Form 3
0
0
No matching records found

NeurogesX Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+71.38%
1.74M
$1.65
$2,877,906.90
4.19M
Jul 21
Form 4
+18.54%
382.17K
$6.18
$2,361,810.60
2.44M
Dec 24
Form 4
+1,015.12%
2.3M
2.53M
May 7
Form 4
227K
$11.00
$2,497,000.00
227K
May 2
Form 3
0
0
No matching records found

Trubion Pharmaceuticals, Inc No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-2.36M
0
Oct 28
Form 4
+3,337.93%
2.29M
2.36M
Oct 23
Form 4
+187.86%
44.64K
$13.00
$580,320.00
68.4K
Oct 17
Form 3
0
0
No matching records found

CELEBRATE EXPRESS, INC. No price found

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
-100.00%
-1.04M
0
Aug 29
Form 4
0
0
Oct 19
Form 4
0
0
Oct 19
Form 4
0
0
Oct 20
Form 3/A
0
0
Form 4
1.04M
1.04M
Oct 25
Form 3
0
0
No matching records found

Sana Biotechnology, Inc. (SANA) Snapshot price: $6.175

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+5.39%
1.82M
$5.50
$9,999,995.50
35.56M
Feb 8
Form 4
+14,957.26%
43.75M
44.04M
Feb 8
Form 3
0
0
No matching records found